NIH-funded research R01 grant

Ultrasound-activated protein nanostructures for targeted gene delivery

Official title: Development of protein-based nanostructures activated by ultrasound

Funded at University of Oklahoma · NIH-11264854 · Data updated 2026-11-12

This project develops tiny protein-built bubbles that are opened with ultrasound to deliver gene-editing tools to specific cells, aiming to help people who might need precise, localized gene therapies.

More Ultrasound research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Oklahoma
NIH-funded
Lab location1 site (Norman, United States)
Project startFebruary 1, 2024
Project endJanuary 31, 2029
Funding year2026
Award (this year)$367,757
NIH project number5R01GM152704-03
Project IDNIH-11264854 on NIH RePORTER

Who could benefit from this research

Could help

People with genetic diseases or conditions that might benefit from localized gene-editing approaches — or patients eligible for early-phase delivery trials of gene therapies — would be the most relevant candidates.

Less likely to help

Patients whose conditions require systemic treatments, are not amenable to gene editing, or who are not eligible for early-phase trials are unlikely to benefit directly from this work.

What this research studies

The team is making gas vesicle-based protein particles that can carry Cas9 ribonucleoprotein (RNP) complexes and related binding proteins. These particles are designed to form localized “protein clouds” that release their cargo when hit with focused ultrasound. Work includes lab tests in cells and animal models to optimize delivery efficiency, cell viability, and targeting across tissues such as the brain and blood vessels. The goal is a platform that could later be used for safer, more precise gene editing in patients.

Why it matters

Potential benefit: If successful, this could make gene-editing treatments safer and more precise by delivering therapeutic molecules only where they are needed.

How similar studies have gone: Related approaches using ultrasound or lipid/nanoparticle delivery have shown promise in lab and animal studies, but using gas-vesicle–linked Cas9 for ultrasound-triggered delivery is a novel and early-stage approach.

Where this research is happening

  • University of Oklahoma
    Norman, United States
    Active

Researchers

  • Principal investigator: Yoon, Sangpil — University of Oklahoma
  • Study coordinator: Yoon, Sangpil

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.